Sangamo Therapeutics | 8-K: Current report
Apr 30 16:57 ET
Sangamo Therapeutics | ARS: Annual Report to Security Holders
Apr 19 16:20 ET
Sangamo Therapeutics | DEF 14A: Definitive information statements
Apr 19 16:06 ET
Sangamo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Apr 5 16:04 ET
Sangamo Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 3 17:21 ET
Sangamo Therapeutics | 8-K: Current report
Mar 25 17:09 ET
Sangamo Therapeutics | 424B5: Prospectus
Mar 25 16:06 ET
Sangamo Therapeutics | 8-K: SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
Mar 13 07:58 ET
Sangamo Therapeutics | 10-K: Annual report
Mar 13 07:53 ET
Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Duraibabu Prathyusha
Feb 27 17:18 ET
Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dubois-Stringfellow Nathalie
Feb 27 17:18 ET
Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Willoughby Scott B.
Feb 27 17:17 ET
Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pooler Amy
Feb 27 17:17 ET
Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Macrae Sandy
Feb 27 17:17 ET
Sangamo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(7.10%)
Feb 13 22:36 ET
Sangamo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biogen Inc.(8.26%),Biogen MA Inc.(8.26%)
Feb 12 19:15 ET
Sangamo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Feb 9 12:20 ET
Sangamo Therapeutics | 8-K: Current report
Feb 6 16:39 ET
Sangamo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(7.9%)
Jan 26 11:54 ET
Sangamo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pooler Amy
Jan 24 16:46 ET
No Data
No Data